Ajay Piramal News
-
Indian billionaire Ajay Piramal acquired a 10 percent stake in Shriram Transport Finance Ltd., a domestic truck-financier, for 16.52 billion rupees ($303 million) to expand his financial services business.
-
Abbott Laboratories will buy Piramal Healthcare Ltd. ’s branded generic-medicine unit in India for $3.72 billion, making it the country’s biggest drugmaker and tapping into a market expected to more than double by 2015.
-
Super Religare Laboratories Ltd. , controlled by billionaire brothers Malvinder and Shivinder Singh, agreed to buy Piramal Healthcare Ltd. ’s diagnostics unit for 6 billion rupees ($129 million) to become India’s largest provider of laboratory services.
-
Piramal Healthcare Ltd. plans to spend 25 billion rupees ($560 million) on a share buyback after the Indian drugmaker sold its domestic generic-medicine business to Abbott Laboratories.
-
Indian billionaire Ajay Piramal may spend $1 billion to acquire biotechnology and defense assets for his health care-to-real estate empire. Investment bankers are unlikely to get a share of that money.
-
Piramal Healthcare Ltd., controlled by Indian billionaire Ajay Piramal, agreed to buy Decision Resources Group LLC, a health-care research provider, for $635 million to tap increasing demand for drug market information.
-
A shortage of injectable drugs in the U.S. means India’s Strides Arcolab Ltd. could sell a division that makes generic cancer treatments and antibiotics for more than the entire company’s market value.
-
The following are some of the important stories that broke overnight, and newspaper summaries in India today:
-
The following are some of the important stories that broke overnight, and newspaper summaries in India today:
-
Telenor ASA, the Nordic region’s biggest phone operator, agreed to sell a 26 percent stake in its Indian mobile phone operations ahead of an auction of spectrum in the country next month.
|
|
Most Popular on Bloomberg
|
| |
Rate this Page